<DOC>
	<DOCNO>NCT00402337</DOCNO>
	<brief_summary>The primary purpose study evaluate efficacy safety administration linaclotide acetate patient chronic constipation .</brief_summary>
	<brief_title>Dose-range-finding , Phase 2 Trial Oral Linaclotide Acetate Administered Patients With Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>Patient 18 year age old Patient meet colonoscopy requirement accord American Gastroenterological Association Patient meet criterion chronic constipation include weekly bowel movement frequency requirement report one symptom constipation accord protocol requirement Patient successfully complete study requirement clinicallysignificant finding : physical exam , ECG , clinical laboratory test Patient fluent English Patient report loose watery stool Patient meet criteria IBS include protocoldefined abdominal discomfort pain Patient may take prohibited medication per protocol Medical diagnosis , medical condition , family history would make patient good candidate study limit patient 's ability complete clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Constipation</keyword>
	<keyword>Chronic Constipation</keyword>
	<keyword>Microbia</keyword>
	<keyword>linaclotide</keyword>
	<keyword>linaclotide acetate</keyword>
	<keyword>MD-1100</keyword>
</DOC>